The pivotal role of vasopressin in refractory anaphylactic shock

Anesthesia and Analgesia

Volumn 107, Issue 2, 2008, Pages 620-624

  Schummer, Claudia ^a   Wirsing, Melanie ^b   Schummer, Wolfram ^c,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c University Hospital of Magdeburg   (Germany)

^d SRH Zentralklinikum Suhl ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; APROTININ; DIPYRONE; GELATIN; INFUSION FLUID; METHYLPREDNISOLONE; NORADRENALIN; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ADULT; ANAPHYLACTIC SHOCK; ARTICLE; BRAIN HEMATOMA; CHRONIC PANCREATITIS; CLINICAL ARTICLE; COLON CARCINOMA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPIDURAL ANESTHESIA; FEMALE; GENERAL ANESTHESIA; GENERAL CONDITION IMPROVEMENT; HEART HEMODYNAMICS; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; AGED; ANAPHYLAXIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PEROPERATIVE COMPLICATION;

AGED; ANAPHYLAXIS; EPINEPHRINE; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 49949116896     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181770b42     Document Type: Article

References (42)

1. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005;5:359-64
2. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:1144-50
3. American Heart Association: guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 10.6: anaphylaxis. Circulation 2005;112:IV143-5
4. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003;97:1381-95
5. Schummer W, Schummer C, Wippermann J, Fuchs J. Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology 2004;101:1025-7
6. Wadell LA. Egyptian civilization: it's sumerian original & real chronology. London: Luzac & Co, 1930
7. Krombach JW, Kampe S, Keller CA, Wright PM. Pharaoh Menes' death after an anaphylactic reaction-the end of a myth. Allergy 2004;59:1234-5
8. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-45
9. Currie M, Webb RK, Williamson JA, Russell WJ, Mackay P. The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21:621-5
10. Lienhart A, Auroy Y, Pequignot F, Benhamou D, Warszawski J, Bovet M, Jougla E. Survey of anesthesia-related mortality in France. Anesthesiology 2006;105:1087-97
11. Mitsuhata H, Matsumoto S, Hasegawa J. [The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan]. Masui 1992;41:1664-9
12. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001;87: 549-58
13. Dietrich W, Spath P, Ebell A, Richter JA. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997;113:194-201
14. Beierlein W, Scheule AM, Dietrich W, Ziemer G. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg 2005;79:741-8
15. Abbas AK. Diseases of immunity. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran pathophysiologic basis of disease. 7th ed. Philadelphia: Elsevier, 2005:193-267. Chap 6
16. Kay AB. Allergy and allergic diseases. Second of two parts. N Engl J Med 2001;344:109-13
17. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986;14:17-21
18. Braun LIB. Notes on desensitisation of a patient hypersensitive to bee stings. S Afr Med Rec 1925;23:408-9
19. Barach EM, Nowak RM, Lee TG, Tomlanovich MC. Epinephrine for treatment of anaphylactic shock. JAMA 1984;251:2118-22
20. Bautista E, Simons FE, Simons KJ, Becker AB, Duke K, Tillett M, Kepron W, Mink SN. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002;128:151-64
21. Mink SN, Simons FE, Simons KJ, Becker AB, Duke K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 2004;34:1776-83
22. Sullivan TJI. Systemic anaphylaxis. In: Lichtenstein LM, Fauci AS, eds. Current therapy in allergy, immunology, and rheumatology Toronto: B.C. Decker, 1988:91-8
23. Wasserman SI, Marquardt DL. Anaphylaxis. In: Middleton EJ, Reed CE, Ellis EF, Adkinson NFJ, Yunginge JW, eds. Allergy: principles and practice. St. Louis: C. V. Mosby, 1988:1365-76
24. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-4
25. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48
26. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ 2003;169:307-11
27. Sneyd JR. Catecholamine-resistant cardiovascular collapse after propofol, atracurium and gentamicin. Eur J Anaesthesiol 1998;15: 600-2
28. McBrien ME, Breslin DS, Atkinson S, Johnston JR. Use of methoxamine in the resuscitation of epinephrine-resistant electromechanical dissociation. Anaesthesia 2001;56:1085-9
29. Heytman M, Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia 2004;59:1210-5
30. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 2004;134:260-1
31. Smith AM, Elliot CM, Kiely DG, Channer KS. The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension. QJM 2006;99:127-33
32. Oliver JA, Landry DW. Endogenous and exogenous vasopressin in shock. Curr Opin Crit Care 2007;13:376-82
33. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95
34. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82
35. Fox AW, May RE, Mitch WE. Comparison of peptide and nonpeptide receptor-mediated responses in rat tail artery. J Cardiovasc Pharmacol 1992;20:282-9
36. Oyama H, Suzuki Y, Satoh S, Kajita Y, Takayasu M, Shibuya M, Sugita K. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J Cereb Blood Flow Metab 1993;13:285-90
37. Peters J, Mack GW, Lister G. The importance of the peripheral circulation in critical illnesses. Intensive Care Med 2001;27: 1446-58
38. Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 2007;106:1156-67
39. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004;59: 993-1001
40. Luckner G, Dunser MW, Stadlbauer KH, Mayr VD, Jochberger S, Wenzel V, Ulmer H, Pajk W, Hasibeder WR, Friesenecker B, Knotzer H. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care 2006;10:R40
41. Opie LH. Receptors and signal transduction. In: Opie LH, ed. The heart: physiology, from cell to circulation. 3rd ed. Philadelphia: Lippincott-Raven, 1998:173-207
42. Bellou A, Lambert H, Gillois P, Montemont C, Gerard P, Vauthier E, Sainte-Laudy J, Longrois D, Gueant JL, Mallie JP. Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock. Shock 2003;19:71-8